Mpm Bioventures 2018, L.p. sold $616k of TRDA
owner at Entrada Therapeutics, Inc.. 86,914 shares at an average of $7.08, traded Aug 27, 2026, filed Aug 31, 2026.
Score components
- +12Role10% owner
- +20Trade size$616k at market
- 0Share of holdings soldSold 2.0% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001231919-26-001136, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -38,922 | $7.20 | $280k | 4,279,426 | 43 d ago |
| Aug 28, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -3,733 | $7.01 | $26k | 4,275,693 | 43 d ago |
| Aug 31, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -44,259 | $6.99 | $309k | 4,231,434 | 43 d ago |
Related signals
Other insiders at Entrada Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. owner | $1.9M 259,837 shares | -6% | |
| 45Moderate | Entrada Therapeutics, Inc. | Mpm Bioventures 2018, L.p. owner | $1.9M 259,837 shares | -6% | |
| 40Moderate | Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. owner | $617k 86,482 shares | -2% | |
| 40Moderate | Entrada Therapeutics, Inc. | Mpm Bioventures 2018, L.p. owner | $617k 86,482 shares | -2% | |
| 40Moderate | Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. owner | $616k 86,914 shares | -2% | |
| 37Weak | Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. owner | $462k 62,714 shares | -1% | |
| 37Weak | Entrada Therapeutics, Inc. | Mpm Bioventures 2018, L.p. owner | $462k 62,714 shares | -1% | |
| 37Weak | Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. owner | $432k 62,811 shares | -2% | |
| 48Moderate | Entrada Therapeutics, Inc. | Kush Parmar director | $1.1M 155,255 shares | -5% | |
| 42Moderate | Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. owner | $807k 116,474 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.